SFI
FLGT icon

Susquehanna Fundamental Investments’s Fulgent Genetics FLGT Stock Holding History

Susquehanna Fundamental Investments’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,816
Closed -$213K – 959
2024
Q1 		$213K Buy
+9,816
New +$244K 0.01% 613
2022
Q4 		– Sell
-15,637
Closed -$596K – 1290
2022
Q3 		$596K Buy
+15,637
New +$784K 0.01% 960
2022
Q1 		$2.16M Buy
34,598
+29,598
+592% +$1.95M 0.04% 553
2021
Q4 		$503K Buy
+5,000
New +$439K 0.01% 911

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Susquehanna Fundamental Investments's FLGT Position: Q2 2024 in Review

Susquehanna Fundamental Investments sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 9,816 shares — an estimated $213K sold.

Susquehanna Fundamental Investments first reported a position in FLGT in Q4 2021 and held it in 4 quarters. The position peaked at $2.16M in Q1 2022. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

  • Susquehanna Fundamental Investments reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 9,816 Fulgent Genetics shares in Q2 2024, an estimated $213K.
  • Susquehanna Fundamental Investments first reported a position in Fulgent Genetics in Q4 2021 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's Fulgent Genetics position peaked at $2.16M in Q1 2022.
  • 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2024, filed 15 Aug 2024.